Callahan Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.8M Sell
109,484
-11,085
-9% -$2.58M 2.23% 13
2025
Q4
$25M Sell
120,569
-3,159
-3% -$625K 2.05% 13
2025
Q3
$22.9M Buy
123,728
+240
+0.2% +$41.1K 1.95% 14
2025
Q2
$18.9M Sell
123,488
-1,564
-1% -$240K 1.7% 15
2025
Q1
$20.7M Buy
125,052
+2,343
+2% +$367K 1.98% 11
2024
Q4
$17.7M Buy
122,709
+4,467
+4% +$692K 1.67% 16
2024
Q3
$19.2M Sell
118,242
-2,487
-2% -$396K 1.87% 12
2024
Q2
$17.6M Buy
120,729
+2,388
+2% +$355K 1.83% 15
2024
Q1
$18.7M Buy
118,341
+1,481
+1% +$236K 1.96% 15
2023
Q4
$18.3M Sell
116,860
-621
-0.5% -$95.2K 2.13% 12
2023
Q3
$18.3M Sell
117,481
-2,614
-2% -$431K 2.3% 10
2023
Q2
$19.9M Buy
120,095
+2,021
+2% +$326K 2.42% 9
2023
Q1
$18.3M Sell
118,074
-4,762
-4% -$769K 2.36% 8
2022
Q4
$21.7M Buy
122,836
+1,398
+1% +$241K 2.97% 5
2022
Q3
$19.8M Buy
121,438
+2,000
+2% +$338K 2.85% 5
2022
Q2
$21.2M Buy
119,438
+198
+0.2% +$35.3K 2.82% 5
2022
Q1
$21.1M Buy
119,240
+1,963
+2% +$334K 2.41% 5
2021
Q4
$20.1M Buy
117,277
+3,039
+3% +$498K 2.25% 8
2021
Q3
$18.4M Buy
114,238
+2,071
+2% +$353K 2.32% 7
2021
Q2
$18.5M Buy
112,167
+988
+0.9% +$164K 2.35% 8
2021
Q1
$18.3M Sell
111,179
-102
-0.1% -$16.5K 2.47% 8
2020
Q4
$17.5M Sell
111,281
-1,662
-1% -$245K 2.56% 8
2020
Q3
$16.8M Sell
112,943
-777
-0.7% -$115K 2.75% 6
2020
Q2
$16M Buy
113,720
+170
+0.1% +$24.8K 2.84% 6
2020
Q1
$14.9M Buy
113,550
+882
+0.8% +$125K 3.13% 5
2019
Q4
$16.4M Buy
112,668
+2,801
+3% +$380K 2.64% 7
2019
Q3
$14.2M Buy
109,867
+869
+0.8% +$114K 2.48% 7
2019
Q2
$15.2M Sell
108,998
-609
-0.6% -$84.3K 2.72% 3
2019
Q1
$15.3M Buy
109,607
+3,186
+3% +$427K 2.85% 5
2018
Q4
$13.7M Buy
106,421
+176
+0.2% +$24.6K 2.93% 4
2018
Q3
$14.7M Buy
106,245
+2,508
+2% +$333K 2.72% 4
2018
Q2
$12.6M Buy
103,737
+1,426
+1% +$178K 2.48% 7
2018
Q1
$13.1M Buy
102,311
+930
+0.9% +$126K 2.69% 6
2017
Q4
$14.2M Sell
101,381
-764
-0.7% -$106K 2.81% 4
2017
Q3
$13.3M Buy
102,145
+979
+1% +$130K 2.79% 2
2017
Q2
$13.4M Sell
101,166
-297
-0.3% -$37.9K 2.91% 2
2017
Q1
$12.6M Buy
101,463
+1,327
+1% +$159K 2.84% 2
2016
Q4
$11.5M Buy
100,136
+795
+0.8% +$91.8K 2.78% 4
2016
Q3
$11.7M Buy
99,341
+6,019
+6% +$730K 2.94% 3
2016
Q2
$11.3M Sell
93,322
-262
-0.3% -$29.8K 2.97% 3
2016
Q1
$10.1M Sell
93,584
-91
-0.1% -$9.42K 2.78% 4
2015
Q4
$9.62M Buy
93,675
+5,598
+6% +$563K 2.74% 5
2015
Q3
$8.22M Buy
88,077
+2,327
+3% +$225K 2.52% 5
2015
Q2
$8.36M Buy
85,750
+2,488
+3% +$249K 2.41% 4
2015
Q1
$8.38M Buy
83,262
+1,958
+2% +$199K 2.44% 3
2014
Q4
$8.5M Buy
81,304
+1,098
+1% +$116K 2.5% 4
2014
Q3
$8.55M Sell
80,206
-290
-0.4% -$30.1K 2.65% 2
2014
Q2
$8.42M Buy
80,496
+1,370
+2% +$138K 2.68% 2
2014
Q1
$7.77M Buy
79,126
+1,037
+1% +$96.1K 2.65% 2
2013
Q4
$7.15M Buy
78,089
+160
+0.2% +$14.7K 2.49% 3
2013
Q3
$6.76M Buy
77,929
+1,422
+2% +$128K 2.58% 2
2013
Q2
$6.57M Buy
+76,507
New +$6.49M 2.69% 2

Other funds holding JNJ

Callahan Advisors's JNJ Position: Q1 2026 in Review

Callahan Advisors reduced its Johnson & Johnson (JNJ) stake by 9.2% in Q1 2026, selling an estimated $2.58M and leaving 109,484 shares worth $26.8M. The position accounts for 2.23% of the portfolio, ranked #13.

Callahan Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Callahan Advisors held 109,484 shares of Johnson & Johnson worth $26.8M as of Q1 2026.
  • Callahan Advisors sold 11,085 Johnson & Johnson shares in Q1 2026, an estimated $2.58M.
  • Johnson & Johnson made up 2.23% of Callahan Advisors's portfolio in Q1 2026, its #13 holding.
  • Callahan Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.